Top Clinical Trials companies in Norway by Total Non-Current Liabilities

This ranking features the top 2 Clinical Trials companies in Norway ranked by Total Non-Current Liabilities, totaling a Total Non-Current Liabilities of USD 1.80 M, for February 07, 2025.

Norway

Clinical Trials
Total Non-Current Liabilities
#
Name
Total Non-Current Liabilities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
LIFE.OL

Lifecare AS

1

LIFE.OL
USD 913.21 K
Dec. 31, 2023 USD 1.13 -2.55%

Norway
2
GENT.OL

Gentian Diagnostics ASA

2

GENT.OL
USD 891.33 K
Dec. 31, 2023 USD 4.31 4.92%

Norway
Frequently Asked Questions
  • Which Clinical Trials company in Norway has the highest Total Non-Current Liabilities ?

    The Clinical Trials company in Norway with the highest Total Non-Current Liabilities is Lifecare AS (Oslo Stock Exchange: LIFE.OL) at USD 913.21 K.

  • Which Clinical Trials company in Norway has the lowest Total Non-Current Liabilities ?

    The Clinical Trials company in Norway with the lowest Total Non-Current Liabilities is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at USD 891.33 K.

  • What are the top 10 Clinical Trials companies in Norway by Total Non-Current Liabilities ?

    The top 10 Clinical Trials companies in Norway by Total Non-Current Liabilities are Lifecare AS and Gentian Diagnostics ASA.

  • What are the bottom 10 Clinical Trials companies in Norway by Total Non-Current Liabilities ?

    The bottom 10 Clinical Trials companies in Norway by Total Non-Current Liabilities are Gentian Diagnostics ASA and Lifecare AS.

SV Wall Street